A Report on Cardio-vascular diseases

Background and objectives

The overall objective of this project was to provide the marketing and new business development teams with a set of well-structured market analysis reports with deep market insights. The report needed to provide commercial attractiveness in each area which would give the commercial teams strategic guidance.

Approach

We organised a workshop with key stakeholders and agreed on the report content and developed shell as listed below:

• Disease burden
  • Epidemiology (prevalence, diagnosis rates, drug treated population, morbidity and mortality and economic cost)
• Medical background
  • Standard of care, treatment protocols and medical guidelines
  • Current gold standard treatment
  • Drug classes and their MOA
  • Delivery of care/pathways to care/patient flow
  • Key players making decisions - from gate keeper to final treatment
  • Diagnostic tools/kits used for diagnosis
  • Specialities in making initial diagnoses and maintaining patients
  • Treatment algorithms - 1st line, 2nd line, 3rd line and by severity
  • Unmet medical needs
  • Shortcomings of current therapies
• Market structures
  • Leading classes, leading products including gold standard, dosage forms/drug delivery
  • Product choice determinants/reasons for drug choice
  • Recent/current trends
• Market dynamics
  • Number of generic products and their efficacy
  • Pricing and reimbursement latitude
  • Regulatory, healthcare policy
• Evaluation of future therapies - Phases IIa and III
  • Pipeline drugs
  • Promising MOA class
  • Promising drug candidates
  • Key issues in clinical trial designs/clinical end points/size/comparators
• New medical  trends
  • Impact of pharmacogenomics
  • Preventative medicine rather than treatment of acute disease, coupled with use of new diagnostic techniques
• Potential value of a compound in this disease state

Results delivered

A detailed report of about 100 pages on major diseases in CV area, containing all references, was delivered to the client.